InspireMD Announces Distribution Agreement in Portugal

- September 21st, 2017

InspireMD announced it has signed an agreement with Medicinália Cormédica MC Medical Lda, a medical distributor in Portugal, to distribute CGuard EPS.

InspireMD (NYSE:NSPR) announced it has signed an agreement with Medicinália Cormédica MC Medical Lda, a medical distributor in Portugal, to distribute CGuard EPS.
As quoted in the press release:

Medicinália Cormédica MC Medical Lda is a subsidiary of WerfenLife Company, one of Europe’s largest distributors of medical products.
Mr. António Cabral, Managing Director of Medicinália Cormédica, noted, “CGuard™ continues to demonstrate its superiority over conventional stents in repeated clinical trials and we look forward to bringing this technology to market in Portugal. Moreover, the clinical data supports the safety and efficacy of carotid artery stenting with CGuard as a minimally invasive alternative to carotid endarterectomy, which further expands the addressable market.”
Agustin Gago, EVP and Chief Commercial Officer of InspireMD, commented, “The addition of Medicinália Cormédica provides us a strong foothold in Portugal, which represents a new market for CGuard™ EPS.

Click here to read the full press release.

Leave a Reply

Your email address will not be published. Required fields are marked *